文献速递间质性肺疾病

间质性肺异常的长期随访:随访策略与风险阈值的启示

Long-Term Follow-Up of Interstitial Lung Abnormality: Implication in Follow-Up Strategy and Risk Thresholds.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01

该回顾性研究纳入305名50岁以上、CT提示间质性肺异常(ILA)的筛查参与者,中位随访11.3年。结果显示,系列CT随访者中ILA进展率为80.5%,进展至普通型间质性肺炎(UIP)者为17.3%,中位进展时间分别为3.2年和11.8年;CT纤维化范围是ILA进展和进展至UIP的独立危险因素。

要点

  • 初次发现ILA者,约每3年复查CT可能适合监测影像学进展。
  • 纤维化范围越大,ILA进展及进展至UIP的风险越高。
  • 据蜂窝影和纤维化范围划分的高风险组10年总生存率差异显著。

核心结论

  • 对初诊ILA者,每3年随访CT可能适合监测影像学进展。
  • 基于纤维化ILA量化范围和蜂窝影的高危人群,可能受益于缩短随访间隔。

研究设计与样本

  • 回顾性研究,纳入50岁及以上、包括不吸烟者的自荐筛查参与者,胸部CT有ILA相关影像表现。
  • 共305名参与者,中位随访11.3年(四分位距8.4-14.3年)。
  • 连续CT评估确定初现ILA和进展的日期,并采用深度学习进行ILA量化。
  • 采用Cox回归分析ILA进展时间及进展至UIP的危险因素。

主要发现

  • 305名参与者中239名(78.4%)至少一次CT存在ILA。
  • 有系列随访CT者中,ILA进展占80.5%(161/200),进展至UIP占17.3%(31/179)。
  • ILA进展中位时间3.2年(95%CI 3.0-3.4年),进展至UIP中位时间11.8年(95%CI 10.8-13.0年)。
  • CT纤维化范围是ILA进展的独立危险因素(HR 1.12,95%CI 1.02-1.23)。
  • CT纤维化范围是进展至UIP的独立危险因素(HR 1.39,95%CI 1.07-1.80)。

关键数值与推荐

  • ILA进展中位时间3.2年(95%CI 3.0-3.4年),进展至UIP中位时间11.8年(95%CI 10.8-13.0年)。
  • 纤维化范围每增加相应单位,ILA进展HR 1.12(95%CI 1.02-1.23),进展至UIP HR 1.39(95%CI 1.07-1.80)。
  • 风险分组依据蜂窝影及纤维化范围(全肺1%或每个肺区5%),10年总生存率差异P=0.02。

临床怎么用

  • 对初诊ILA者,可考虑约3年间隔的随访CT以监测影像学进展。
  • 对纤维化范围较大或伴蜂窝影的高危ILA者,可考虑缩短随访CT间隔。
  • 随访中结合深度学习ILA量化评估纤维化范围,辅助风险分层。

局限性

  • 为回顾性研究,纳入自荐筛查参与者,可能存在选择偏倚。
  • 随访CT间隔与进展判定依赖既有影像资料,非预设统一方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: The optimal follow-up computed tomography (CT) interval for detecting the progression of interstitial lung abnormality (ILA) is unknown. Objectives: To identify optimal follow-up strategies and extent thresholds on CT relevant to outcomes. Methods: This retrospective study included self-referred screening participants aged 50 years or older, including nonsmokers, who had imaging findings relevant to ILA on chest CT scans. Consecutive CT scans were evaluated to determine the dates of the initial CT showing ILA and the CT showing progression. Deep learning-based ILA quantification was performed. Cox regression was used to identify risk factors for the time to ILA progression and progression to usual interstitial pneumonia (UIP). Measurements and Main Results: Of the 305 participants with a median follow-up duration of 11.3 years (interquartile range, 8.4-14.3 yr), 239 (78.4%) had ILA on at least one CT scan. In participants with serial follow-up CT studies, ILA progression was observed in 80.5% (161 of 200), and progression to UIP was observed in 17.3% (31 of 179), with median times to progression of 3.2 years (95% confidence interval [CI], 3.0-3.4 yr) and 11.8 years (95% CI, 10.8-13.0 yr), respectively. The extent of fibrosis on CT was an independent risk factor for ILA progression (hazard ratio, 1.12 [95% CI, 1.02-1.23]) and progression to UIP (hazard ratio, 1.39 [95% CI, 1.07-1.80]). Risk groups based on honeycombing and extent of fibrosis (1% in the whole lung or 5% per lung zone) showed significant differences in 10-year overall survival (P = 0.02). Conclusions: For individuals with initially detected ILA, follow-up CT at 3-year intervals may be appropriate to monitor radiologic progression; however, those at high risk of adverse outcomes on the basis of the quantified extent of fibrotic ILA and the presence of honeycombing may benefit from shortening the interval for follow-up scans.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Park S, Choe J, Hwang HJ, et al. Long-Term Follow-Up of Interstitial Lung Abnormality: Implication in Follow-Up Strategy and Risk Thresholds. Am J Respir Crit Care Med. 2023. PMID: 37590877. doi:10.1164/rccm.202303-0410OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。